DatasetName,KHNYN_S(10) KHNYN_S(170) KHNYN_S(331) KHNYN_S(370) KHNYN_T(413),KHNYN_S(291) KHNYN_S(342) KHNYN_S(353) KHNYN_S(359)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5825324092685044,0.5764869598236542
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.5138059748023167
SR2019_LM2_Biol_repl_1,0.6259496320959088,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,0.4570184380906154
AH2018_LFQ_IT_1_C,0.5696480319281452,
RKK2015_TNF-α/basal,,0.5047526807642881
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,0.4681886880076603
NJH2025_Sub7_MICT_Post,,0.46379788056994065
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5075233649425057
HS2024_6_B_T3,,0.4308108557621245
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.5338675443651073,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5805806742976964,0.4616277737607868
SR2019_MDAMB231_Biol_repl_4,0.634112821020589,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,0.43539300076686704
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,0.46755171555239466
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,0.5829937788257606,
HS2024_7_B_N1,,0.5932110799551646
FSO2013_Ratio M/L normalized Rep1___1,0.5806741654710013,
SAS2015_AZD/DMSO_Exp3,,0.46285026856935546
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5578542632798177,0.5438295426339468
WZ2023_Pu_010_30min,0.5860247035422314,0.48620563558047536
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5965861089487813,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5897705475744749,
AH2018_SILAC_MR_2_N,0.5946592477385523,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,0.46139856489997116
LY2019_P1+,0.5744885925840133,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5380685204989788
EP2017_Pervanadate R#3 normalized log2 ratio,0.5874934665330976,0.4157482945657371
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5100154557239995
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5764711181322565,0.46495150089301107
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5780259955008419,0.4980562125201516
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,0.45398218541313695
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5788806022441724,0.5013252911530024
AH2018_SILAC_MR_2_X,0.5938005425453005,
HS2024_4_PD_T2,,0.4406506228070047
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5662156257381867,0.46191989543906453
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5852167566421603,
CR2017_Ratio Replicate 1.3,0.5861475070373993,0.5704612126506989
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5645046006828116,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5704390031350648,
HS2024_7_PD_T2,0.6137740672903746,0.5043535468377935
FSO2013_Ratio H/L normalized Rep1___1,0.5749021930791474,
AH2018_LFQ_1_C,0.5895199260792022,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.5557755483854437,0.46836921512175034
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5818399449562234,0.4765872658767518
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,0.562533990232619,
AH2018_SILAC_2_X,0.5683512674045332,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5933808206354177,
FSO2013_Ratio H/L normalized Rep2,0.5898353509211333,0.5383266173053265
WZ2023_Pu_005_20min,0.587133639421334,0.5089597983499139
NJH2024_Sub10_MICT_Post,,0.4504465288920964
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5775349655945139,0.4857459309718033
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5941248330362564,0.5032138354228691
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5938832221020173,
NJH2025_Sub7_MICT_Pre,,0.457126612556989
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.4798362306807143
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.4582857070782691
FSO2013_Ratio M/L normalized Rep3___2,,0.5792959038817832
SR2019_BT549_Biol_repl_3,0.6244959540591839,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.4587671398910044
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,
PG2020_Intensity Mock_10h_D,0.5638574678844213,
SR2019_MCF10A_Biol_repl_2,0.6029012772920047,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.4850753742116818
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5828897168327353,0.397825966338458
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,0.5171288386087697
CR2017_Ratio Replicate 3.3,0.5909798532464151,0.5733145636045922
PG2020_Intensity 2h_C,0.5376431551629463,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5061543348671158
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,0.4504465288920964
HS2024_6_I_T3,,0.47192552638905605
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.57504831289996,
HS2024_5_PD_T1,0.5846252522795952,0.5344967250439142
AH2018_LFQ_M_2_C,0.5929428095599455,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5712314127840082,0.530532794320707
YA2020_Reporter_intensity_Cancer_No.5,0.5673957485051695,0.4808612111706091
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,0.5857475125606549,
NJH2025_Sub2_HIIT_Post,,0.44590618491833367
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5026664563269228
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,0.5787505615208582,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5655882385453312,
YA2020_Reporter_intensity_Normal_No.1,0.5909778057996927,0.5052099069425191
HS2024_3_B_T1,,0.4178672101249942
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,0.5892395911354651,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,0.4579678150310712
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.6131633353853416,0.6308390865348652
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.5287680406809907
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.581918606776209,0.4881837372734927
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,0.4570184380906154
AH2018_LFQ_IT_1_N,0.5722858603213353,
FSO2013_Ratio H/M normalized Rep2,0.5790713832880938,0.5540019042871438
RAM2015_Log2 A,,0.4889035133085503
HS2024_8_PD_T1,0.5899616622495227,0.6410121079742006
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5980898545984134,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5994288996110989,
HS2024_7_I_T1,0.5837903185732245,0.5282272034165083
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,0.5143377307396431
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5461847599340517,0.44580544024293167
AH2018_SILAC_M_3_X,0.5655519454842892,
NJH2024_Sub9_HIIT_Post,,0.45205582540801315
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5879881095213616,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5568293047325175,0.5388225650724177
HS2024_6_B_N1,0.5756345388447434,0.47611319879005065
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,0.5686871825966417,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,0.46755171555239466
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5617372452657987,
JAW2011_Ratio H/L,0.5752030367322314,
PG2020_Intensity 10h_C,0.5963721616081854,
FSO2013_Ratio M/L normalized Rep2,0.5887969430642478,0.5558546255860779
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.6087056155563929,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,0.4695604870969895
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,0.46550014186100197
AH2018_LFQ_4_C,0.5851009831230861,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.48935026734739295
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5613828959327702,
EJN2021_4_Rest_Ins,0.5805882987683487,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,0.46227979776093964
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5698383613598543,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5682999830464056,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5693692549815553,
CK2022_11 200-1,,
CK2022_12 200-1,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5857599607880879,0.4907499192847206
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,0.45883087862063
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.5703256951488574,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,0.4579417705140091
CF2017_OSE 26,,
CK2022_14 200-1,,
SR2019_Hs578T_Biol_repl_1,0.5869031756267994,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,0.46962489616826497
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5756944448846447,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,0.46550014186100197
EJN2021_2_Rest_Ins,0.58335459887309,
SR2019_LM2_Biol_repl_4,0.6277550024104899,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.5801758056259125,
HS2024_7_I_T3,0.6596679243201492,0.5866360732439868
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5751204140405222,0.4822022837936393
CF2017_EOC 1,,
CK2022_3 200-1,,
AH2018_LFQ_IT_3_C,0.5684181059824812,
SR2019_Hs578T_Biol_repl_2,0.5932680287761877,
NJH2024_Sub12_HIIT_Post,,0.4729895387183471
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,0.458674692751688
NJH2024_Sub13_MICT_Post,,0.4605857734197916
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.5070017970619055
HS2024_5_B_T1,0.5141272791241395,0.43058105414608117
CW2012_10 µM Gef/control Experiment 2 Replicate A,0.5916164030330787,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.633202281099835,
HS2024_3_B_T2,0.5319741637864803,0.4380529647212004
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.550905339073253
HS2024_4_B_T1,0.5653466790075351,0.48764957400688036
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.6215824806161094,
EJN2021_1_Rest_Basal,0.5737748140284538,
NJH2025_Sub8_MICT_Post,,0.4626197658766924
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5870853120921915,0.5373111809686675
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5779396706951165,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,0.44900621328938795
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.587666742359735,0.5108916828729124
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5683335022817385,
HS2024_5_PD_T3,0.5469615093597906,0.4119070633252046
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.4342954171511786
AH2018_SILAC_M_1_N,0.5730519311497766,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5781272586002705,0.5037305903318553
NJH2025_Sub13_HIIT_Pre,,0.4579417705140091
PG2020_Intensity CT_D,0.573737723705085,
NJH2025_Sub9_MICT_Post,,0.44941330622195247
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,0.592439317780587,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.44660600671648587
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.47232376347073685
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5818700322656195,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,0.46962489616826497
NJH2024_Sub8_MICT_Pre,,0.46445738678994325
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5685896208315505,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5832175124197011,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.611413693247149,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5620877784938496,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.5807310832849313,0.4934811981385815
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,0.4532506950947831
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5882939115114596,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,0.4600423923412663
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5842622657679618,0.5130842147493403
HS2024_8_B_T2,0.6647644608653047,0.6025693628842905
AH2018_LFQ_1_X,0.5920529259032876,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5649136023327392,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5724124174004667,0.4958965162263187
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.5811505790407592
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.6137750078804423,0.7193269497669095
SR2019_LM2_Biol_repl_3,0.6250786447628244,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5806502016628077,
CW2012_10 µM Erl/control Experiment 2 Replicate A,0.5816455035800903,
FSO2013_Ratio H/M normalized Rep3,0.5871564587582514,0.6112849799109206
AR2021_KD 72h,,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,0.4626197658766924
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.5665383838876883,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5805126637459556,
PG2020_Intensity Mock_10h_C,0.5611293331915211,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.5794450336341199
PG2020_Intensity 10h_A,0.586644556299154,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,0.4628737268170153
AH2018_LFQ_IT_4_C,0.565367989827412,
SAS2015_PLX/AZD_Exp1,,0.5104353678805719
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5685946190948501,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,0.4729895387183471
EJN2021_4_Ex_Basal,0.5750141008079283,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5803208661474865,
FSO2013_Ratio H/M normalized Rep2___2,,0.5585514330748813
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,0.4579678150310712
KS2014_Intensity C3,0.5862526111328952,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.6437823679210679,0.5649865017586353
CK2022_7 200-1,,
CK2022_5 200-1,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5901277111690852,
NJH2024_Sub10_HIIT_Mid,,0.44838716886747676
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5883916982602544,
AH2018_SILAC_MR_1_X,0.5941110383383716,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.5709681143593697,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5653701471543009,
EJN2021_5_Rest_Ins,0.5851514413984666,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5659312161611548,0.4206379390627286
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5827515773334596,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,0.47189730876780156
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,0.46139856489997116
PG2020_Intensity 6h_B,0.576496698141489,
FSO2013_Ratio H/L normalized Rep3,0.5893073419449769,0.5921189016443742
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5980834810197178
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,0.4670487615021009
HS2024_6_B_N2,0.5709966167887369,0.45905201771850174
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5602211392261098,
AH2018_SILAC_IT_1_X,0.5609178599894751,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.6222626082597603,0.4791725845157361
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.5782007881563125,0.46524691746752755
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5855604006194446,
HS2024_4_I_N2,0.5082254947974774,0.4645412383053781
AH2018_TMTMS2_3_N,,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.45758357230839375
WZ2023_Su_005_30min,0.5820642927443507,0.503530382952651
SR2019_HCC1419_Biol_repl_4,0.6128435509642525,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,0.45271335242799976
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,0.5849351878413331,0.5027614848507354
AH2018_LFQ_IT_4_X,0.5644223388312812,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5880246539515707,0.5149066638394703
CW2012_10 µM Gef/control Experiment 1 Replicate B,0.601698116992057,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,0.5640374244189655,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5786430218643039,0.4143791434363431
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.6042017955648917,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.595108429479324,
LY2019_P7+,0.5672206009529632,
EP2017_Untreated R#1 normalized log2 ratio,0.5711331818542555,0.44946206882848194
RN2012_L10,,
PG2020_Intensity 4h_C,0.5677823026417317,
EP2017_Mitotic R#3 normalized log2 ratio,0.5791680915798052,0.40799073967013144
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5608268209063153,
HS2024_4_B_T3,0.5454339271125311,0.43425855273365127
NJH2024_Sub2_HIIT_Post,,0.44590618491833367
HS2024_8_B_N2,0.5761085833628841,0.5134823106240335
NJH2025_Sub8_HIIT_Pre,,0.4600423923412663
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.6040482390939885,0.5820163577360018
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5829172160302911,0.41852999385743317
GF2025_P9_Sph,,
CK2022_6 200-1,,
NJH2024_Sub7_MICT_Post,,0.46379788056994065
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,0.4626336791917799
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.6055987439654209,
HS2024_4_I_T2,0.5472038926612828,0.43471496889758965
NJH2024_Sub2_MICT_Mid,,0.4670487615021009
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.4817604184762907
SAS2015_AZD/DMSO_Exp1,,0.46311417905767144
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.5777324581696439,
HS2024_3_B_T3,0.5451560895920177,0.43736996819967056
MV2014_Ratio L/H normalized A3___2 (2 min),,0.512486370338973
NJH2025_Sub13_MICT_Pre,,0.45883087862063
SR2019_MDAMB231_Biol_repl_3,0.6312679851339186,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5752247748176523,
EP2017_Untreated R#3 normalized log2 ratio,0.5748224460238535,0.34187264189871275
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,0.4620514473819451
JAW2011_Ratio H/L LS2,0.5782781649511437,
CK2022_8 200-1,,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5784755016011848,0.5463461710206009
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.594413816018091,0.46221609732314506
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5684251611470647,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.4940627187064795
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.6740569741833016,0.6071332137769807
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,0.5794025581822855,
HS2024_6_B_T2,,0.44987892136202245
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,0.5858691966633007,
SAS2015_PLX/DMSO_Exp2,,0.47006405273630614
EJN2021_1_Ex_Basal,0.5616780643120175,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5769679303965805,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5633983051421806,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5731000674795304,0.33788546746076453
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5948280371982893,0.5801118232601383
HS2024_8_PD_T2,0.6103164521052289,0.6141446508219137
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,0.45205582540801315
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.6181208488532121,0.5655973627921904
NJH2025_Sub10_MICT_Mid,,0.458674692751688
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.4852812255380814
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5855505831735789,0.5562968906521215
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,0.5838338190210055,0.5026938544906887
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,0.4605857734197916
HS2024_4_B_N2,,0.5043197111901941
HS2024_3_PD_T3,0.5484131557667352,0.48505276481604354
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,0.4541484765621022
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.590191360194791,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,0.48673599268606305
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.4653085185992778
NJH2025_Sub8_MICT_Pre,,0.46445738678994325
EJN2021_4_Rest_Basal,0.5823963154361607,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.4169364680044351
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,0.45271335242799976
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.6272337825139175
PG2020_Intensity Mock_10h_B,0.5688240853032339,
WZ2023_Su_025_30min,0.5834053000250042,0.4943894269638693
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.5779170675975095,0.5338072781426936
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.58403929066535,0.5535693365798705
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.5734144453664328,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5760893903199362,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5711987138387208,0.43942186272350536
NJH2025_Sub7_HIIT_Mid,,0.46227979776093964
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.6010975559465599,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,0.5907141312339963,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,0.46603741936051923
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,0.46418485505955764
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.547003524695541,0.4508132910401183
SR2019_BT549_Biol_repl_1,0.6212195962996863,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,0.4603826959166144
PG2020_Intensity 8h_B,0.5930733686934035,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.6012977640682954,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5696480007661953,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5662922566483594
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5613189357879474,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5847460551704822,0.5598057130611565
ZQ2022_N1,,
LY2019_P6-,0.5857125935493037,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,0.4697772391379128
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5905006873828996,
RKK2015_TNF-α/IKKb,,0.49907559373730703
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,0.44838716886747676
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,0.57618024700538,
PG2020_Intensity 4h_B,0.5708652180348439,
SR2019_BT549_Biol_repl_2,0.6201128147404347,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5657422356720805,0.4814316546283761
WZ2023_Su_025_20min,0.5877599217294239,0.5055351533801276
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.5749748137894268,
LY2019_P8-,0.5700423653355544,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5721353167948591,0.4223159868395216
NJH2024_Sub2_HIIT_Pre,,0.46603741936051923
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.5824021937715402,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5447087160888107,0.4563421528526754
EJN2021_4_Ex_Ins,0.5809386310261901,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5732542790051747,
EP2017_Pervanadate R#3 log2 ratio,0.5861640273617351,0.40765373425041135
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5761479092329711,
AH2018_LFQ_M_4_C,0.5901489568796816,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5623609014056442,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5773882856300635,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5772547265772573,0.4705103232186644
HS2024_8_PD_T3,0.58467566334057,0.5878151891713657
EJN2021_3_Ex_Basal,0.5832075171802081,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5299564245397289,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.582533768983171,0.4793351446507088
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.6060349760822072,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5858078528225658,0.5290605868261905
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5731517894198104,0.5685822944064632
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5724445242344665,
LY2019_P8+,0.5730314415526279,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.6009786554107903,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5928154180255906,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,0.4546819190389908
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.5961795673284837,
AH2018_LFQ_IT_1_X,0.5725296174074923,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5788613190016247,0.4768273096434962
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.45166740128227667
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,0.5964505803329855,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,0.44941330622195247
CF2017_OSE 28,,
HS2024_5_B_T2,0.520654078144052,0.4504108273412171
HS2024_6_I_T1,0.6009135452648684,0.4635929364963666
HS2024_5_B_T3,0.5474197265001424,0.45372185917508606
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,0.6127046221344112,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5950091186631793,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,0.4603826959166144
EP2017_Mitotic R#3 log2 ratio,0.5792112189050851,0.4118222295776107
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5841158109367945,0.49833570955451467
KS2014_Intensity C2,0.6014913717149778,
FSO2013_Ratio H/L normalized Rep1___2,,0.4256677084771108
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,
NJH2024_Sub9_MICT_Mid,,0.4532506950947831
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5967583187221663,0.5342444027606137
RBK2021_1332T Late,,
LY2019_P1-,0.6052747565914757,
RKK2015_TNF-α/basal.1,,0.5056912024277986
RKK2015_TNF-α/TNF-α+SC-514,,0.493215095006624
CR2017_Ratio Replicate 2.5,0.5887268213053977,0.6136866813847525
HS2024_3_I_T3,,0.44529103076806714
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6090243391873921,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5861541542660526,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,0.6121378126892174
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5694424895537111,0.4439934079766477
RKK2015_SC-514/basal,,0.523539960988253
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5858111973163329,0.4812615047246691
NJH2025_Sub9_HIIT_Mid,,0.45398218541313695
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5636116749116326,0.5328569001223318
KS2014_Intensity N1,0.5552419504630418,
NJH2024_Sub12_MICT_Post,,0.4697772391379128
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.596348278623662,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,0.4574347442438661
AH2018_SILAC_MR_3_X,0.5951506085943153,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.549721104156536,0.4085314905789112
HS2024_5_I_N1,0.5441626658712481,0.4268020039847794
HS2024_6_I_N1,0.5678977743771803,0.46949318121381906
AR2021_KD 48h,,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.4323914920531272
NJH2024_Sub10_MICT_Pre,,0.4641259708313925
SR2019_LM2_Biol_repl_2,0.6235425675899641,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.6377899290005138,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5796991718074885,0.48090444624543266
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5815056838947485,0.49882363684994835
AH2018_LFQ_M_2_X,0.5953174288226976,
AH2018_LFQ_IT_4_N,0.5655333262771282,
CK2022_15 200-1,,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5751494148043668,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.586515865107115,0.4975105989297482
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5744150978533077,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5803378720454033,0.4213386142692465
HS2024_8_B_T3,,0.5580692228072539
YA2020_Reporter_intensity_Cancer_No.3,0.5725538720988737,0.4790329213947056
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.5759606724785682,0.4745099980369973
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.6027334152581675,
FSO2013_Ratio H/M normalized Rep3___1,0.5872415671790865,
AH2018_SILAC_M_3_C,0.566533058600071,
RKK2015_TNF-α+IKKb/TNF-α,,0.5747378837437493
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5696064556685329,
AH2018_SILAC_M_2_X,0.5674846740292632,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5858228111298731,0.5036893515057957
PG2020_Intensity 6h_C,0.5786264165193067,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5952548211619674,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5843473513584276,
FSO2013_Ratio H/L normalized Rep3___2,,0.5947122753856944
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5439098650356897,0.44121932072770975
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,0.4548143298964623
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,0.43539300076686704
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,0.4695604870969895
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,0.46068375347191837
IMM2018_normalised rep. int. CDK5L-1,0.5758070135358301,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5821287266554415,0.41839056480128733
EJN2021_2_Ex_Basal,0.5844278574797872,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.6034909876314531
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5723064285605528,
NJH2024_Sub10_HIIT_Pre,,0.4541484765621022
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,0.46418485505955764
HS2024_3_PD_T2,0.5569153553037826,0.46888836646647375
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.5047098838540018
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,0.6350136357453462
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,0.4641259708313925
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5048216657409095
KS2014_Intensity C4,0.6098540363179277,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,0.44900621328938795
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5937397659915667,0.4938851974065471
SAS2015_PLX/DMSO_Exp3,,0.46705389840465844
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,0.4548143298964623
AH2018_LFQ_M_3_C,0.5930169904594403,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5717318999726799,0.4918026274899143
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.568879376777495,
WZ2023_Pu_025_10min,0.5787786113119275,0.4871918217236091
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5821446823316507,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5770530043717796,0.4814346701027785
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.569313856848427,
KS2014_Intensity C6,0.5839809336857475,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,0.457126612556989
ZX2022_Control Replicate 1,,0.5011743660316051
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5692180081402959,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5888242315315427,
UK2020_UA_3,,
LY2019_P7-,0.5859055238651354,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,0.5765563612955064,
FSO2013_Ratio H/L normalized Rep3___1,0.5894243471499279,
SR2019_HCC1954_Biol_repl_3,0.6080821541576231,
CR2017_Ratio Replicate 2.2,0.5759517782756189,0.5278925571543609
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5393160253498441,
PG2020_Intensity CT_B,0.5660548477586812,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5748760766676231,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,0.4546819190389908
JAW2011_Ratio H/L_1,0.5747667109516332,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5882076583659088,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,0.4626336791917799
AH2018_LFQ_M_3_X,0.5934125924938473,
YA2020_Reporter_intensity_Cancer_No.4,0.5705294341207154,0.49144932961089255
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.4259427600402187
HS2024_8_I_T1,0.7016703227024909,0.5856874520749454
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5822117632094603,0.3982370881209332
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.5887194830863484,
NJH2025_Sub8_MICT_Mid,,0.4628737268170153
EJN2021_5_Ex_Ins,0.5820714535227371,
HS2024_6_I_N2,0.5553624360550327,0.4871395845046108
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,0.4681886880076603
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,0.47622881447103443
AH2018_SILAC_1_X,0.572588024592571,
PG2020_Intensity 10h_B,0.5874605218014811,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,0.4574347442438661
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,0.4620514473819451
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,0.5853512941869232
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5912086556667943,
SR2019_HCC1419_Biol_repl_3,0.6126628204170714,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.6152709742552721,0.7259458255641691
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5928904948303981,
HS2024_5_I_N2,0.5435362653478293,0.48070277125584765
SAS2015_PLX/AZD_Exp3,,0.4928193643917804
EP2017_Pervanadate R#2 log2 ratio,0.5934072769655514,0.4547135651399765
AS2011_Ratio H/L Normalized RNAi_2_1,,
